한글목차

세계의 양막 제품 시장은 2024년에 8억 5,123만 달러로 평가되며, 예측 기간에는 13억 1,777만 달러에 달할 것으로 예측되며, 2030년까지 CAGR은 7.53%입니다.

세계의 양막 제품 시장은 재생 치료, 첨단 상처 관리 솔루션, 혁신적인 수술 용도에 대한 수요 증가로 인해 꾸준히 성장하고 있습니다. 양막 및 관련 제품이 조직 회복을 촉진하고 염증을 감소시키며 흉터를 최소화하는 임상적 이점에 대한 인식이 높아지면서 성장의 원동력이 되고 있습니다. 가공 및 보존 기술의 혁신은 더 높은 품질과 다용도한 제품을 만들어 정형외과, 안과, 성형외과에 적용 범위를 넓혀가고 있습니다. 연구개발에 대한 투자가 증가함에 따라 효능과 안전성을 개선한 새로운 제제가 등장하고 있습니다. 이 시장은 다양한 치료 영역에서 환자 결과를 개선할 수 있는 양막 제품의 잠재력을 인식한 의료 서비스 프로바이더들 사이에서 수용이 확대되고 있습니다.

시장 동향은 양막 제품의 임상 적용을 확대하기 위한 제품 혁신과 전략적 파트너십에 초점을 맞추고 있음을 알 수 있습니다. 복잡한 질환에 대응하기 위해 이러한 생물제제를 다른 치료법과 통합하는 병용 요법을 개발하는 방향으로의 전환이 두드러지게 나타나고 있습니다. 임상시험과 과학적 연구는 양막 제품의 치료적 가치를 강화하고 있으며, 첨단 상처 치료 관리 및 재생 의학에 활용되고 있습니다. 차세대 제품을 위한 길을 열어줄 바이오소재와 조직공학의 지속적인 발전으로 기회가 창출되고 있습니다. 생명공학 기업, 연구기관, 의료 서비스 프로바이더 간의 협력적 노력은 제품 개발과 시장 개발의 새로운 길을 열어가고 있습니다.

주요 시장 성장 촉진요인

재생의료에 대한 수요 증가

주요 시장이 해결해야 할 과제

규제 장벽과 컴플라이언스 문제

기증자 조직에서 유래한 양막 제품의 자연적 편차는 일관된 품질을 유지하고 규제 기준을 충족하는 데 어려움을 겪을 수 있습니다.

주요 시장 동향

동결 보존 양막 제품의 채택 증가

목차

제1장 제품 개요

제2장 조사 방법

제3장 개요

제4장 고객의 소리

제5장 세계의 양막 제품 시장 전망

• 시장 규모·예측
  • 금액별
• 시장 점유율·예측
  • 유형별(동결 보존 양막, 탈수 양막)
  • 용도별(창상관리, 정형외과, 안과, 기타)
  • 최종사용자별(병원, 외래 수술 센터, 기타)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 양막 제품 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 양막 제품 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 양막 제품 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 양막 제품 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 양막 제품 시장 전망

• 시장 규모·예측
• 시장 점유율·예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 촉진요인과 과제

제12장 시장 동향과 발전

• 최근 동향
• 제품 출시
• 합병과 인수

제13장 세계의 양막 제품 시장 : SWOT 분석

제14장 경쟁 구도

• MiMedx Group, Inc.
• Integra LifeSciences Holdings Corporation
• Organogenesis Holdings, Inc.
• Amnio technology LLC
• Alliqua Biomedical, Inc.
• Human Regenerative Technologies, LLC
• Corza Ophthalmology Inc.
• BioTissue Holdings, Inc.
• Applied Biologics LLC

제15장 전략적 제안

제16장 조사회사 소개·면책사항

영문목차

Global Amniotic Products Market was valued at USD 851.23 Million in 2024 and is expected to reach USD 1317.77 Million in the forecast period with a CAGR of 7.53% through 2030. The Global Amniotic Products Market is experiencing steady expansion driven by rising demand for regenerative therapies, advanced wound care solutions, and innovative surgical applications. Growth is fueled by an increasing awareness of the clinical benefits of amniotic membrane and related products in accelerating tissue repair, reducing inflammation, and minimizing scarring. Technological innovations in processing and preservation techniques have resulted in higher quality and more versatile products, thereby broadening their application in orthopedics, ophthalmology, and plastic surgery. Increased investments in research and development have led to the emergence of novel formulations that offer enhanced efficacy and safety profiles. The market is witnessing growing acceptance among healthcare providers who recognize the potential of amniotic products to improve patient outcomes in various therapeutic areas.

Trends in the market reveal a focus on product innovation and strategic partnerships to expand the clinical applications of amniotic products. There is a notable shift toward developing combination therapies that integrate these biologics with other treatment modalities to address complex medical conditions. Clinical trials and scientific studies are reinforcing the therapeutic value of amniotic membrane products, which are being leveraged in advanced wound care management and regenerative medicine. Opportunities arise from the ongoing evolution in biomaterials and tissue engineering, which are paving the way for next-generation products. Collaborative efforts among biotechnology firms, research institutions, and healthcare providers are creating new avenues for product development and market penetration.

Key Market Drivers

Increasing Demand for Regenerative Medicine

The field of regenerative medicine has witnessed a remarkable surge in interest and demand, and this wave of enthusiasm has not bypassed the Global Amniotic Products Market. Regenerative medicine is a multidisciplinary approach that seeks to restore or enhance the body's natural ability to heal and regenerate damaged tissues. The primary reasons behind the escalating demand for regenerative medicine is its patient-centric approach. Patients today are increasingly seeking treatments that not only alleviate symptoms but also address the root causes of their medical conditions. Regenerative therapies, including amniotic products, have emerged as a promising avenue in this regard. They offer the potential for long-term healing and restoration of function, rather than just short-term relief. According to the U.S. National Institutes of Health (NIH), funding for regenerative medicine research increased by 15% from 2022 to 2023, reaching nearly USD 2.8 billion, which underscores the growing investment in this field.

Key Market Challenges

Regulatory Hurdles and Compliance Issues

One of the foremost challenges facing the Amniotic Products Market is the complex regulatory landscape governing the use of these products. Regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have stringent requirements for product safety, efficacy, and labeling. Compliance with these regulations demands substantial resources, time, and expertise.

Amniotic products are categorized as biological drugs or medical devices, subjecting them to rigorous testing and approval processes. Meeting the requirements for clinical trials and pre-market approval can be time-consuming and costly. The regulatory landscape for regenerative therapies is continually evolving. Changes in regulations and guidelines can lead to uncertainty for manufacturers and potentially impact market access.

The natural variability of amniotic products derived from donor tissues can pose challenges in maintaining consistent quality and meeting regulatory standards.

Key Market Trends

Increasing Adoption of Cryopreserved Amniotic Products

One prominent trend in the Global Amniotic Products Market is the increasing adoption of cryopreserved amniotic products. Cryopreservation involves the freezing and long-term storage of amniotic tissues while preserving their biological activity. This method offers several advantages:

Cryopreservation significantly extends the shelf life of amniotic products, allowing for easier distribution and use in various healthcare settings. Cryopreserved amniotic products retain their biological properties, such as growth factors and cytokines, ensuring that they remain efficacious when used in clinical applications. Healthcare providers can access cryopreserved amniotic products as needed, reducing the need for fresh tissue procurement and processing, which can be time-consuming.

Key Market Players

• MiMedx Group, Inc.
• Integra LifeSciences Holdings Corporation
• Organogenesis Holdings, Inc.
• Amnio technology LLC
• Alliqua Biomedical, Inc.
• Human Regenerative Technologies, LLC
• Corza Ophthalmology Inc.
• BioTissue Holdings, Inc.
• Applied Biologics LLC

Report Scope:

In this report, the Global Amniotic Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Amniotic Products Market, By Type:

• Cryopreserved Amniotic Membranes
• Dehydrated Amniotic Membranes

Amniotic Products Market, By Application:

• Wound Care
• Orthopedics
• Ophthalmology
• Others

Amniotic Products Market, By End-User:

• Hospitals & Ambulatory Surgical Centers
• Other

Amniotic Products Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Amniotic Products Market.

Available Customizations:

Global Amniotic Products market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Amniotic Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes)
  • 5.2.2. By Application (Wound Care, Orthopedics, Ophthalmology, Others)
  • 5.2.3. By End-User (Hospitals & Ambulatory Surgical Centers, Other)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Amniotic Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Application
  • 6.2.3. By End-User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Amniotic Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Amniotic Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Amniotic Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By End-User

7. Europe Amniotic Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Application
  • 7.2.3. By End-User
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Amniotic Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By End-User
  • 7.3.2. United Kingdom Amniotic Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By End-User
  • 7.3.3. Italy Amniotic Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By End-User
  • 7.3.4. France Amniotic Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Amniotic Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By End-User

8. Asia-Pacific Amniotic Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Application
  • 8.2.3. By End-User
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Amniotic Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By End-User
  • 8.3.2. India Amniotic Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By End-User
  • 8.3.3. Japan Amniotic Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By End-User
  • 8.3.4. South Korea Amniotic Products Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Application
      • 8.3.4.2.3. By End-User
  • 8.3.5. Australia Amniotic Products Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Application
      • 8.3.5.2.3. By End-User

9. South America Amniotic Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Application
  • 9.2.3. By End-User
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Amniotic Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By End-User
  • 9.3.2. Argentina Amniotic Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By End-User
  • 9.3.3. Colombia Amniotic Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By End-User

10. Middle East and Africa Amniotic Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Application
  • 10.2.3. By End-User
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Amniotic Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By End-User
  • 10.3.2. Saudi Arabia Amniotic Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By End-User
  • 10.3.3. UAE Amniotic Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers & Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Amniotic Products Market: SWOT Analysis

14. Competitive Landscape

• 14.1. MiMedx Group, Inc.
• 14.2. Integra LifeSciences Holdings Corporation
• 14.3. Organogenesis Holdings, Inc.
• 14.4. Amnio technology LLC
• 14.5. Alliqua Biomedical, Inc.
• 14.6. Human Regenerative Technologies, LLC
• 14.7. Corza Ophthalmology Inc.
• 14.8. BioTissue Holdings, Inc.
• 14.9. Applied Biologics LLC

15. Strategic Recommendations

16. About Us & Disclaimer